| | |
| Insight: Cancer drugs proving worth earlier in testing Sunday, Feb 24, 2013 10:43 PM PST  NEW YORK (Reuters) - Michael Weitz was out of options. The Californian had endured chemotherapy, radiation and surgery but his lung cancer still spread to his bones and brain. With time running out, the emergency room physician entered a Phase I study - the earliest stage of human testing for a new medicine - of crizotinib. The drug works for about 4 percent of advanced lung cancer patients with a mutated form of a protein called ALK. ... Full Story | Top |
| Pediatricians oppose school suspension, expulsion Sunday, Feb 24, 2013 09:21 PM PST NEW YORK (Reuters Health) - A group representing pediatricians says disciplining students with out-of-school suspension or expulsion is counterproductive to school goals and should only be used on case by case basis. The policy statement from the American Academy of Pediatrics (AAP) recommends that pediatricians familiarize themselves with the policies of their local school districts, and advocate for prevention and alternative strategies. "The adverse effect of out-of-school suspension and expulsion on the student can be profound," the experts write in the journal Pediatrics on Monday. ... Full Story | Top |
| Tanning parlors may misinform clients about risks Sunday, Feb 24, 2013 09:20 PM PST NEW YORK (Reuters Health) - Tanning facilities often given inconsistent or incorrect information about the risks associated with indoor tanning and may let kids as young as 10 or 12 tan, according to a new study from Missouri. Although the U.S. Food and Drug Administration (FDA) has some guidelines on proper safety precautions for indoor tanning, those aren't enforced by states if the state government doesn't pass its own regulations, researchers explained. ... Full Story | Top |
| Yum says to step up check on suppliers after China scare Sunday, Feb 24, 2013 06:09 PM PST  BEIJING (Reuters) - Yum Brands Inc will tighten its monitoring of suppliers and improve testing of poultry as it aims to reverse a steep drop in business at its KFC restaurants in China after a chicken safety scare. In a statement ahead of a media briefing in Beijing on Monday, the company also said it would look to improve its communications with the Chinese government and people in the wake of the scare. ... Full Story | Top |
| Cochlear implants aid adults with hearing loss: study Sunday, Feb 24, 2013 04:13 PM PST (Reuters) - Cochlear implants can improve speech and quality of life in adults with severe hearing loss - and two implants seem to work better than one, according to a U.S. analysis of past research. The study, which appeared in JAMA Otolaryngology - Head & Neck Surgery, included 42 studies that compared hearing, speech and quality of life in eligible adults before and after they received a cochlear implant or compared having one versus two functioning implants. According to the U.S. National Institutes of Health, about 17 percent of U.S. ... Full Story | Top |
| Study says too many Americans still drink too much Sunday, Feb 24, 2013 04:01 PM PST  (Reuters) - On any given day in the United States, 18 percent of men and 11 percent of women drink more alcohol than federal guidelines recommend, according to a study that also found that 8 percent of men and 3 percent of women are full-fledged "heavy drinkers." That means the great majority of Americans stay within the advised limit of two drinks a day for men and one for women, according to the study that appeared in the Journal of the Academy of Nutrition and Dietetics. ... Full Story | Top |
| Affymax, Takeda recall anemia drug Omontys after deaths Sunday, Feb 24, 2013 10:22 AM PST TOKYO/WASHINGTON (Reuters) - U.S.-based Affymax Inc and Japan's Takeda Pharmaceutical Co said they are voluntarily recalling all lots of anemia treatment Omontys (peginesatide) in the United States due to reports of serious hypersensitivity reactions, including some deaths. As of Sunday, fatal reactions to the injection have been reported in about 0.02 percent of 25,000 patients after receiving their initial injection of the treatment, Affymax said in a statement. ... Full Story | Top |
| Latest Simpson-Bowles health plan stirs worry but lacks detail Sunday, Feb 24, 2013 08:34 AM PST  WASHINGTON (Reuters) - A new bipartisan deficit-reduction plan to slash a massive $600 billion from U.S. healthcare spending over two decades has policy experts scratching their heads over how such an ambitious target can be reached. Democrat Erskine Bowles and Republican Alan Simpson have yet to declare what they would do to wring savings from Medicare, Medicaid and other programs, according to analysts who provide the two deficit hawks with their facts and figures. Those ideas will be laid out in a detailed plan due to be issued at some point over the coming weeks. ... Full Story | Top |
|
No comments:
Post a Comment